Inhibitory effect of somatostatin peptide analogues on DNA polymerase activity and human cancer cell proliferation

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4841-4850

  Kuriyama, Isoko ^a   Miyazaki, Anna ^a,b   Tsuda, Yuko ^a,b   Yokoi, Toshio ^a,b   Okada, Yoshio ^b   Takeuchi, Toshifumi ^c   Sugawara, Fumio ^a,c   Yoshida, Hiromi ^a   Mizushina, Yoshiyuki ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b Hoshi University   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Anticancer effect; Apoptosis; Cell cycle arrest; Enzyme inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; DNA POLYMERASE; ETOPOSIDE; FUNCTIONAL GROUP; H TYROSYL DEXTRO TRYPTOPHYL 1 ADAMANTYLAMIDE; H TYROSYL DEXTRO TRYPTOPHYL 1 CYCLOHEXAMIDE; H TYROSYL DEXTRO TRYPTOPHYL 1 NAPHTHYLAMIDE; H TYROSYL DEXTRO TRYPTOPHYL 2 ADAMANTYLAMIDE; H TYROSYL DEXTRO TRYPTOPHYLLYSYL(BENZYLOXYCARBONYL) HYDROXIDE; SOMATOSTATIN DERIVATIVE; TERT BUTYLOXYCARBONYL GROUP; TERT BUTYLOXYCARBONYLTYROSYL DEXTRO TRYPTOPHYL 1 ADAMANTYLAMIDE; TERT BUTYLOXYCARBONYLTYROSYL DEXTRO TRYPTOPHYL 1 CYCLOHEXAMIDE; TERT BUTYLOXYCARBONYLTYROSYL DEXTRO TRYPTOPHYL 1 NAPHTHYLAMIDE; TERT BUTYLOXYCARBONYLTYROSYL DEXTRO TRYPTOPHYL 2 ADAMANTYLAMIDE; TERT BUTYLOXYCARBONYLTYROSYL DEXTRO TRYPTOPHYLLYSYL(BENZYLOXYCARBONYL) HYDROXIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DNA REPLICATION; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELL CYCLE; CELL GROWTH PROCESSES; CELL SURVIVAL; DNA, NEOPLASM; DNA-DIRECTED DNA POLYMERASE; HCT116 CELLS; HUMANS; MODELS, MOLECULAR; PEPTIDES; RATS; SOMATOSTATIN;

EID: 78751550611     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kornberg A and Baker T: DNA Replication, 2nd edition. New York. 1992.
2. Bebenek K and Kunkel TA: In: DNA Repair and Replication: Advances in Protein Chemistry. Yang W (ed.). SanDiego. pp. 137-165, 2004.
3. Friedberg EC, Feaver WJ and Gerlach VL: The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance. Proc Natl Acad Sci USA 97: 5681-5683, 2000.
4. Maga G and Hubscher U: Repair and translesion DNA polymerases as anticancer drug targets. Anticancer Agents Med Chem 8: 431-447, 2008. (Pubitemid 351761428)
5. Sakaguchi K, Sugawara F and Mizushina Y: Inhibitors of eukaryotic DNA polymerases. Seikagaku 74: 244-251, 2002.
6. So AG and Downey KM: Eukaryotic DNA replication. Crit Rev Biochem Mol Biol 27: 129-155, 1992.
7. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J and Guillemin R: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79, 1973.
8. Moreau SC, Murphy WA and Coy DH: Comparison of somatuline (BIM-23014) and somatostatin on endocrine and exocrine activities in the rat. Drug Dev Res 22: 79-93, 1991.
9. Reichlin S: Somatostatin. N Engl J Med 309: 1495-1501, 1983.
10. Breder CD, Yamada Y, Yasuda K, Seino S, Saper CB and Bell GI: Differential expression of somatostatin receptor subtypes in brain. J Neurosci 12: 3920-3934, 1992.
11. Bruno JF, Xu Y, Song J and Berelowitz M: Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133: 2561-2567, 1993.
12. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ and Pless: SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sei 31: 1133-1140, 1982.
13. Hofland LJ, Visser-Wisselaar HA and Lamberts SW: Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50: 287-297, 1995.
14. Kaupmann K, Bruns C, Raulf F, Weber H P, Mattes H and Lubbert H: Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J 14: 727-735, 1995.
15. Srkalovic G, Cai RZ and Schally AV: Evaluation of receptors for somatostatin in various tumors using different analogs. J Clin Endocrinol Metab 70: 661-669, 1990. (Pubitemid 120009878)
16. Weckbecker G, Raulf F, Stolz B and Bruns C: Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther 60: 245-264, 1993.
17. Kéri G, Erchegyi J, Horvath A, Mezo I, Idei M, Vantus T, Balogh A, Vadasz Z, Bokonyi G, Seprodi J, Teplán I, Csuka O, Tejeda M, Gaal D, Szegedi Z, Szende B, Roze C, Kalthoff H and Ullrich A: A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci USA 93: 12513-12518, 1996.
18. Kéri G, Mezo I, Vadász Z, Horváth A, Idei M, Vantus T, Balogh A, Bokonyi G, Bajor T, Teplán I, Tamas J, Mak M, Horváth J and Csuka O: Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Pept Res 6: 281-288, 1993. (Pubitemid 2007680)
19. Miyazaki A, Tsuda Y, Fukushima S, Yokoi T, Vantus T, Bokonyi G, Szabo E, Horvath A, Kéri G and Okada Y: Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative properties. J Med Chem 5/: 5121-5124, 2008.
20. Miyazaki A, Tsuda Y, Fukushima S, Yokoi T, Vántus T, Bokonyi G, Szabó E, Horváth A, Kéri G and Okada Y: New cyclic somatostatin analogues containing a pyrazinone ring: Importance of Tyr for antiproliferative activity. Bioorg Med Chem Lett 18: 6199-6201, 2008.
21. Miyazaki A, Yokoi T, Tachibana Y, Enomoto R, Lee E, Bokonyi G, Kéri G, Tsuda Y and Okada Y: Design and synthesis of novel type somatostatin analogs with antiproliferative activities on A431 tumor cells. Tetrahedron Lett 45: 6323-6327, 2004. (Pubitemid 39055820)
22. Tamai K, Kojima K, Hanaichi T, Masaki S, Suzuki M, Umekawa H and Yoshida S: Structural study of immunoaffinity-purified DNA polymerase ct-DNA primase complex from calf thymus. Biochim Biophys Acta 950: 263-273, 1988.
23. Date T, Yamaguchi M, Hirose F, Nishimoto Y, Tanihara K and Matsukage A: Expression of active rat DNA polymerase β in Escherichia coli. Biochemistry 27: 2983-2990, 1988.
24. Umeda S, Muta T, Ohsato T, Takamatsu C, Hamasaki N and Kang D: The D-loop structure of human mtDNA is destabilized directly by 1-methyl-4- phenylpyridinium ion (MPP+), a parkinsonism-causing toxin. Eur J Biochem 267: 200-206, 2000.
25. Oshige M, Takenouchi M, Kato Y, Kamisuki S, Takeuchi T, Kuramochi K, Shiina I, Suenaga Y, Kawakita Y, Kuroda K, Sato N, Kobayashi S, Sugawara F and Sakaguchi K: Taxol derivatives are selective inhibitors of DNA polymerase a. Bioorg Med Chem 12: 2597-2601, 2004.
26. Kusumoto R, Masutani C, Shimmyo S, Iwai S and Hanaoka F: DNA binding properties of human DNA polymerase eta: implications for fidelity and polymerase switching of translesion synthesis. Genes Cells 9: 1139-1150, 2004. (Pubitemid 39618529)
27. Ohashi E, Murakumo Y, Kanjo N, Akagi J, Masutani C, Hanaoka F and Ohmori H: Interaction of hREVl with three human Yfamily DNA polymerases. Genes Cells 9: 523-531, 2004.
28. Shimazaki N, Yoshida K, Kobayashi T, Toji S, Tamai K and Koiwai O: Over-expression of human DNA polymerase X in E. coli and characterization of the recombinant enzyme. Genes Cells 7: 639-651, 2002.
29. Sakaguchi K, Hotta Y and Stern H: Chromatin-associated DNA polymerase activity in meiotic cells of lily and mouse. Cell Struct Funct 5: 323-334, 1980.
30. Mizushina Y, Tanaka N, Yagi H, Kurosawa T, Onoue M, Seto H, Horie T, Aoyagi N, Yamaoka M, Matsukage A, Yoshida S and Sakaguchi K: Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitro. Biochim Biophys Acta 1308: 256-262, 1996.
31. Mizushina Y, Yoshida S, Matsukage A and Sakaguchi K: The inhibitory action of fatty acids on DNA polymerase β. Biochim Biophys Acta 1336: 509-521, 1997.
32. Ogawa A, Múrate T, Suzuki M, Nimura Y and Yoshida S: Lithocholic acid, a putative tumor promoter, inhibits mammalian DNA polymerase β. Jpn J Cancer Res 59: 1154-1159, 1998.
33. Tamiya-Koizumi K, Murate T, Suzuki M, Simbulan C M, Nakagawa M, Takemura M, Furuta K, Izuta S and Yoshida S: Inhibition of DNA primase by sphingosine and its analogues parallels with their growth suppression of cultured human leukemic cells. Biochem Mol. Biol Int 41: 1179-1189, 1997. (Pubitemid 27232077)
34. Oda M, Ueno T, Kasai N, Takahashi H, Yoshida H, Sugawara F, Sakaguchi K, Hayashi H and Mizushina Y: Inhibition of telomerase by linear-chain fatty acids: a structural analysis. Biochem J 367: 329-334, 2002.
35. Ohta K, Mizushina Y, Hirata N, Takemura M, Sugawara F, Matsukage A, Yoshida S and Sakaguchi K: Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIV-reverse transcriptase type 1 from a marine red alga, Gigartina tenella. Chem Pharm Bull (Tokyo) 46: 684-686, 1998.
36. Nakayama C and Saneyoshi M: Differential inhibitory effects of 5-substituted 1-β-D-xylofuranosyluracil 5'-triphosphates and related nucleotides on DNA-dependent RNA polymerases I and II from the cherry salmon (Oncorhynchus masou). J Biochem (Tokyo) 95: 417-425, 1985. (Pubitemid 15243771)
37. Yonezawa Y, Hada T, Uryu K, Tsuzuki T, Eitsuka T, Miyazawa T, Murakami-Nakai C, Yoshida H and Mizushina Y: Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation. Biochem Pharmacol 70: 453-460, 2005. (Pubitemid 40905117)
38. Soltis DA and Uhlenbeck OC: Isolation and characterization of two mutant forms of T4 polynucleotide kinase. J Biol Chem 257: 11332-11339, 1982.
39. Lu BC and Sakaguchi K: An endo-exonuclease from meiotic tissues of the basidiomycete Coprinus cinereus: Its purification and characterization. J Biol Chem 266: 21060-21066, 1991.
40. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y and Ueno K: A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19: 1518-1520, 1996.
41. Mizushina Y: Specific inhibitors of mammalian DNA polymerase species. Biosci Biotechnol Biochem 73: 1239-1251, 2009.
42. Loeb LA and Monnat RJ Jr.: DNA polymerases and human disease. Nat Rev Genet 9: 594-604, 2008.
43. Orzeszko A, Gralewska R, Starosciak B J and Kazimierczuk Z: Synthesis and antimicrobial activity of new adamantane derivatives I. Acta Biochim Pol 47: 87-94, 2000.